InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Gannon Steven, Director. Officer active across 2 companies, notably Fusion Pharmaceuticals Inc.. In total, 9 disclosures have been recorded. Split: 4 buys · 3 sells. Total volume traded: €746k. History available since 16 August 2021. The latest transaction was filed on 11 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gannon Steven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
10,000 shares@ US$64.0550.010% mcap84.7% of flowCommon SharesSEC:0001193125-26-349351:0
3 shares@ US$30.480.1% of flowCommon SharesSEC:0000950170-25-083321:0
5,144 shares@ US$12.5757.6% of flowCommon SharesSEC:0000950170-25-073746:0
56,400 sharesCommon StockSEC:0000950170-24-068906:0
1,000 shares@ US$46.4542.4% of flowCommon SharesSEC:0000950170-24-028788:0
44,400 shares@ US$2.0341.5% of flowCommon StockSEC:0001209191-22-045421:0
Canonical exit: 9 Nov 2022 (T+90)
2,829 shares@ US$7.98512.9% of flowCommon StockSEC:0001209191-21-053000:0
Canonical exit: 21 Nov 2021 (T+90)
171 shares@ US$8.050.8% of flowCommon StockSEC:0000899243-21-033814:0
Canonical exit: 16 Nov 2021 (T+90)
6,000 shares@ US$8.1027.7% of flowCommon StockSEC:0000899243-21-033258:0
Canonical exit: 14 Nov 2021 (T+90)
9 of 9 declarations
About Gannon Steven
GANNON STEVEN is Administrateur of Fusion Pharmaceuticals Inc. and Xenon Pharmaceuticals Inc. He has 9 filings in total, and across the sampled recent filings from 2021-08-17 to 2026-08-13, buys amount to EUR 149032 and sells to EUR 597220.
